303 related articles for article (PubMed ID: 12416896)
21. [Measurement of antiganglioside autoantibodies by immunodot-blot assay: clinical importance in peripheral neuropathies].
Caudie C; Vial C; Petiot P; Bancel J; Later R; Gonnaud PM
Ann Biol Clin (Paris); 1999; 57(5):579-88. PubMed ID: 10518060
[TBL] [Abstract][Full Text] [Related]
22. A novel O-acetylated ganglioside detected by anti-GD2 monoclonal antibodies.
Ye JN; Cheung NK
Int J Cancer; 1992 Jan; 50(2):197-201. PubMed ID: 1730513
[TBL] [Abstract][Full Text] [Related]
23. Differential expression of gangliosides and galactolipids in fetal human oligodendrocytes and astrocytes in culture.
Satoh JI; Tai T; Kim SU
Brain Res Dev Brain Res; 1996 May; 93(1-2):172-81. PubMed ID: 8804704
[TBL] [Abstract][Full Text] [Related]
24. GD1b-specific antibody induces ataxia in Guillain-Barre syndrome.
Kaida K; Kamakura K; Ogawa G; Ueda M; Motoyoshi K; Arita M; Kusunoki S
Neurology; 2008 Jul; 71(3):196-201. PubMed ID: 18625966
[TBL] [Abstract][Full Text] [Related]
25. Ganglioside complexes as new target antigens in Guillain-Barré syndrome.
Kaida K; Morita D; Kanzaki M; Kamakura K; Motoyoshi K; Hirakawa M; Kusunoki S
Ann Neurol; 2004 Oct; 56(4):567-71. PubMed ID: 15389898
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of human neuroblastoma cell proliferation and EGF receptor phosphorylation by gangliosides GM1, GM3, GD1A and GT1B.
Mirkin BL; Clark SH; Zhang C
Cell Prolif; 2002 Apr; 35(2):105-15. PubMed ID: 11952645
[TBL] [Abstract][Full Text] [Related]
27. Ganglioside reactive antibodies of IgG and IgM class in sera of patients with differentiated thyroid cancer.
Lewartowska A; Pacuszka T; Adler G; Panasiewicz M; Wojciechowska W
Immunol Lett; 2002 Feb; 80(2):129-32. PubMed ID: 11750045
[TBL] [Abstract][Full Text] [Related]
28. Anti-ganglioside antibodies in amyotrophic lateral sclerosis revisited.
Kollewe K; Wurster U; Sinzenich T; Körner S; Dengler R; Mohammadi B; Petri S
PLoS One; 2015; 10(4):e0125339. PubMed ID: 25875836
[TBL] [Abstract][Full Text] [Related]
29. Ganglioside antibodies: a lack of diagnostic specificity and clinical utility?
Weller M; Stevens A; Sommer N; Dichgans J; Kappler B; Wiethölter H
J Neurol; 1992 Oct; 239(8):455-9. PubMed ID: 1447574
[TBL] [Abstract][Full Text] [Related]
30. IgM anti-ganglioside antibodies induced by melanoma cell vaccine correlate with survival of melanoma patients.
Takahashi T; Johnson TD; Nishinaka Y; Morton DL; Irie RF
J Invest Dermatol; 1999 Feb; 112(2):205-9. PubMed ID: 9989797
[TBL] [Abstract][Full Text] [Related]
31. Autoantibodies against ganglioside GM3 are associated with narcolepsy-cataplexy developing after Pandemrix vaccination against 2009 pandemic H1N1 type influenza virus.
Saariaho AH; Vuorela A; Freitag TL; Pizza F; Plazzi G; Partinen M; Vaarala O; Meri S
J Autoimmun; 2015 Sep; 63():68-75. PubMed ID: 26227560
[TBL] [Abstract][Full Text] [Related]
32. Cerebrospinal fluid antibodies directed against neuron-associated gangliosides in HIV-1 infection.
Gisslén M; Lekman A; Fredman P
Infection; 2000; 28(3):143-8. PubMed ID: 10879637
[TBL] [Abstract][Full Text] [Related]
33. Association of antibodies to ganglioside complexes and conduction blocks in axonal Guillain-Barré syndrome presenting as acute motor conduction block neuropathy.
Créange A; Shahrizaila N; Salhi H; Lefaucheur JP; Yuki N
J Peripher Nerv Syst; 2014 Jun; 19(2):115-20. PubMed ID: 24750296
[TBL] [Abstract][Full Text] [Related]
34. Patterns of serum IgM antibodies to GM1 and GD1a gangliosides in amyotrophic lateral sclerosis.
Pestronk A; Adams RN; Cornblath D; Kuncl RW; Drachman DB; Clawson L
Ann Neurol; 1989 Jan; 25(1):98-102. PubMed ID: 2913936
[TBL] [Abstract][Full Text] [Related]
35. How useful are anti-neural IgM antibodies in the diagnosis of chronic immune-mediated neuropathies?
Nobile-Orazio E; Gallia F; Terenghi F; Allaria S; Giannotta C; Carpo M
J Neurol Sci; 2008 Mar; 266(1-2):156-63. PubMed ID: 17915254
[TBL] [Abstract][Full Text] [Related]
36. Chronic idiopathic sensory ataxic neuropathy: immunological aspects of a series of 17 patients.
Illa I; Rojas R; Gallardo E; Serrano C; Graus F
Rev Neurol (Paris); 2001 May; 157(5):517-22. PubMed ID: 11438771
[TBL] [Abstract][Full Text] [Related]
37. Antiganglioside antibodies in Guillain-Barré syndrome after a recent cytomegalovirus infection.
Khalili-Shirazi A; Gregson N; Gray I; Rees J; Winer J; Hughes R
J Neurol Neurosurg Psychiatry; 1999 Mar; 66(3):376-9. PubMed ID: 10084538
[TBL] [Abstract][Full Text] [Related]
38. Anti-ganglioside antibodies in patients with systemic lupus erythematosus and neurological manifestations.
Labrador-Horrillo M; Martinez-Valle F; Gallardo E; Rojas-Garcia R; Ordi-Ros J; Vilardell M
Lupus; 2012 May; 21(6):611-5. PubMed ID: 22323340
[TBL] [Abstract][Full Text] [Related]
39. Serological response patterns of melanoma patients immunized with a GM2 ganglioside conjugate vaccine.
Kitamura K; Livingston PO; Fortunato SR; Stockert E; Helling F; Ritter G; Oettgen HF; Old LJ
Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2805-9. PubMed ID: 7708728
[TBL] [Abstract][Full Text] [Related]
40. Induction of antibodies against GD3 ganglioside in melanoma patients by vaccination with GD3-lactone-KLH conjugate plus immunological adjuvant QS-21.
Ragupathi G; Meyers M; Adluri S; Howard L; Musselli C; Livingston PO
Int J Cancer; 2000 Mar; 85(5):659-66. PubMed ID: 10699946
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
